[HTML][HTML] Tumor cell invasion in glioblastoma
A Vollmann-Zwerenz, V Leidgens, G Feliciello… - International journal of …, 2020 - mdpi.com
Glioblastoma (GBM) is a particularly devastating tumor with a median survival of about 16
months. Recent research has revealed novel insights into the outstanding heterogeneity of …
months. Recent research has revealed novel insights into the outstanding heterogeneity of …
Tumor Cell Invasion in Glioblastoma
A Vollmann-Zwerenz, V Leidgens… - International …, 2020 - pubmed.ncbi.nlm.nih.gov
Glioblastoma (GBM) is a particularly devastating tumor with a median survival of about 16
months. Recent research has revealed novel insights into the outstanding heterogeneity of …
months. Recent research has revealed novel insights into the outstanding heterogeneity of …
[PDF][PDF] Tumor Cell Invasion in Glioblastoma
A Vollmann-Zwerenz, V Leidgens… - Int. J. Mol …, 2020 - pdfs.semanticscholar.org
Glioblastoma (GBM) is a particularly devastating tumor with a median survival of about 16
months. Recent research has revealed novel insights into the outstanding heterogeneity of …
months. Recent research has revealed novel insights into the outstanding heterogeneity of …
Tumor Cell Invasion in Glioblastoma.
A Vollmann-Zwerenz, V Leidgens… - … Journal of Molecular …, 2020 - europepmc.org
Glioblastoma (GBM) is a particularly devastating tumor with a median survival of about 16
months. Recent research has revealed novel insights into the outstanding heterogeneity of …
months. Recent research has revealed novel insights into the outstanding heterogeneity of …
Tumor Cell Invasion in Glioblastoma
A Vollmann-Zwerenz, V Leidgens… - International …, 2020 - epub.uni-regensburg.de
Glioblastoma (GBM) is a particularly devastating tumor with a median survival of about 16
months. Recent research has revealed novel insights into the outstanding heterogeneity of …
months. Recent research has revealed novel insights into the outstanding heterogeneity of …
Tumor Cell Invasion in Glioblastoma.
A Vollmann-Zwerenz, V Leidgens… - International …, 2020 - search.ebscohost.com
Glioblastoma (GBM) is a particularly devastating tumor with a median survival of about 16
months. Recent research has revealed novel insights into the outstanding heterogeneity of …
months. Recent research has revealed novel insights into the outstanding heterogeneity of …
Tumor Cell Invasion in Glioblastoma
A Vollmann-Zwerenz, V Leidgens… - International …, 2020 - search.proquest.com
Glioblastoma (GBM) is a particularly devastating tumor with a median survival of about 16
months. Recent research has revealed novel insights into the outstanding heterogeneity of …
months. Recent research has revealed novel insights into the outstanding heterogeneity of …
Tumor Cell Invasion in Glioblastoma
A Vollmann-Zwerenz, V Leidgens, G Feliciello… - International Journal of …, 2020 - cir.nii.ac.jp
抄録< jats: p> Glioblastoma (GBM) is a particularly devastating tumor with a median survival
of about 16 months. Recent research has revealed novel insights into the outstanding …
of about 16 months. Recent research has revealed novel insights into the outstanding …
Tumor cell invasion in glioblastoma
A Vollmann-Zwerenz, V Leidgens, G Feliciello… - 2020 - publica.fraunhofer.de
Glioblastoma (GBM) is a particularly devastating tumor with a median survival of about 16
months. Recent research has revealed novel insights into the outstanding heterogeneity of …
months. Recent research has revealed novel insights into the outstanding heterogeneity of …
[HTML][HTML] Tumor Cell Invasion in Glioblastoma
A Vollmann-Zwerenz, V Leidgens… - … Journal of Molecular …, 2020 - ncbi.nlm.nih.gov
Glioblastoma (GBM) is a particularly devastating tumor with a median survival of about 16
months. Recent research has revealed novel insights into the outstanding heterogeneity of …
months. Recent research has revealed novel insights into the outstanding heterogeneity of …